Joint Venture12 Dec 2025, 11:52 am
Lupin Manufacturing Solutions and PolyPeptide Announce Strategic Alliance to Scale Global Peptide Supply Chain
AI Summary
Lupin Manufacturing Solutions (LMS), a subsidiary of global pharma major Lupin Limited, and PolyPeptide Group AG have formed a long-term strategic alliance. This collaboration aims to enhance supply chain resilience, improve operational efficiency, and accelerate readiness for the rapidly expanding global peptides market. The partnership strengthens LMS as a leading CDMO supplier of peptide materials and enhances PolyPeptide’s position as a trusted CDMO partner, particularly in the area of metabolic diseases.
Key Highlights
- Lupin Manufacturing Solutions and PolyPeptide Group AG announce a strategic alliance to enhance global peptide supply chain
- The alliance aims to improve operational efficiency and accelerate readiness for the rapidly expanding global peptides market
- The partnership strengthens LMS's position as a leading CDMO supplier of peptide materials and enhances PolyPeptide’s position as a trusted CDMO partner
- The collaboration focuses on enhancing supply chain resilience, particularly in the area of metabolic diseases
- The alliance is expected to ensure reliable access to specialized materials that support large-scale commercial production